Top
  • Company
    • Overview
    • Leadership
    • Board of Directors
    • Contact Us
  • Science
    • ST266 Biologic
    • Key Mechanisms to Healing
    • Innovative Delivery Options
    • Scalable Manufacturing
    • Publications
  • Pipeline
    • Current Programs
    • Other Programs
    • Clinical Trials
  • News
    • Press Releases
  • Careers
    • Why Noveome?
    • Hear From Our Employees
    • Pittsburgh Please
    • Competitive Benefits
    • Career Opportunities
  • Company
    • Overview
    • Leadership
    • Board of Directors
    • Contact Us
  • Science
    • ST266 Biologic
    • Key Mechanisms to Healing
    • Innovative Delivery Options
    • Scalable Manufacturing
    • Publications
  • Pipeline
    • Current Programs
    • Other Programs
    • Clinical Trials
  • News
    • Press Releases
  • Careers
    • Why Noveome?
    • Hear From Our Employees
    • Pittsburgh Please
    • Competitive Benefits
    • Career Opportunities

Author: admin

Sustained release of amnion-derived cellular cytokine solution facilitates achilles tendon healing in rats

Posted on August 4, 2014October 3, 2019 by admin

Kueckelhaus, M., et al.,

Continue reading “Sustained release of amnion-derived cellular cytokine solution facilitates achilles tendon healing in rats” →

Posted in Publication

Amnion-derived multipotent progenitor cells improve achilles tendon repair in rats.

Posted on June 19, 2013October 3, 2019 by admin

Philip, J., et al.,

Continue reading “Amnion-derived multipotent progenitor cells improve achilles tendon repair in rats.” →

Posted in Publication

Amnion-derived multipotent progenitor cells support allograft tolerance induction.

Posted on June 13, 2013October 3, 2019 by admin

Anam, K., et al.,

Continue reading “Amnion-derived multipotent progenitor cells support allograft tolerance induction.” →

Posted in Publication

Long-term administration of amnion-derived cellular cytokine suspension promotes functional recovery in a model of penetrating ballistic-like brain injury

Posted on August 7, 2012October 3, 2019 by admin

Deng-Bryant, Y., et al.,

Continue reading “Long-term administration of amnion-derived cellular cytokine suspension promotes functional recovery in a model of penetrating ballistic-like brain injury” →

Posted in Publication

Individualized, targeted wound treatment based on the tissue bacterial level as a biological marker

Posted on August 20, 2011October 3, 2019 by admin

Pierpont, Y.N., et al.,

Continue reading “Individualized, targeted wound treatment based on the tissue bacterial level as a biological marker” →

Posted in Publication

Amnion-derived cellular cytokine solution promotes macrophage activity.

Posted on May 5, 2011October 3, 2019 by admin

Uberti, M.G., et al.,

Continue reading “Amnion-derived cellular cytokine solution promotes macrophage activity.” →

Posted in Publication

Synergism of human amnion-derived multipotent progenitor (AMP) cells and a collagen scaffold in promoting brain wound recovery:

Posted on January 12, 2011October 3, 2019 by admin

Chen, Z., et al.,

Continue reading “Synergism of human amnion-derived multipotent progenitor (AMP) cells and a collagen scaffold in promoting brain wound recovery:” →

Posted in Publication

Effect of amnion-derived cellular cytokine solution on healing of experimental partial-thickness burns

Posted on July 7, 2010October 3, 2019 by admin

Payne, W.G., et al.,

Continue reading “Effect of amnion-derived cellular cytokine solution on healing of experimental partial-thickness burns” →

Posted in Publication

Amnion-derived cellular cytokine solution (ACCS) promotes migration of keratinocytes and fibroblasts.

Posted on May 5, 2010October 3, 2019 by admin

Uberti, M.G., et al.,

Continue reading “Amnion-derived cellular cytokine solution (ACCS) promotes migration of keratinocytes and fibroblasts.” →

Posted in Publication

Human amnion-derived multipotent progenitor cell treatment alleviates traumatic brain injury-induced axonal degeneration

Posted on November 11, 2009October 3, 2019 by admin

Chen, Z., et al.,

Continue reading “Human amnion-derived multipotent progenitor cell treatment alleviates traumatic brain injury-induced axonal degeneration” →

Posted in Publication

Posts navigation

Older posts
Newer posts

Recent Posts

  • Noveome Biotherapeutics, Inc. Announces Issuance of U.S. Patent No. 12,121,546 Entitled, “Treatment of Systemic Inflammatory Responses”
  • Noveome Biotherapeutics, Inc. Announces Completion of Treatment of the First Baby in its Phase 1-2 Clinical Trial Evaluating ST266 in the Treatment of Necrotizing Enterocolitis in Premature Infants
  • Noveome Biotherapeutics, Inc. Receives FDA Notification to Proceed with its Phase 1-2 Clinical Trial in Treatment of NEC
  • Noveome Biotherapeutics, Inc. Completes First Close of $40 Million Series E Financing to Support Clinical Trials in NEC
  • Noveome Biotherapeutics, Inc. Announces New Appointments to Board of Directors

Recent Comments

    Archives

    • November 2024
    • December 2023
    • August 2023
    • November 2022
    • May 2022
    • January 2022
    • June 2021
    • May 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • October 2019
    • September 2019
    • June 2019
    • May 2019
    • April 2019
    • May 2018
    • April 2018
    • January 2018
    • November 2017
    • January 2017
    • November 2015
    • July 2015
    • September 2014
    • August 2014
    • June 2013
    • August 2012
    • August 2011
    • May 2011
    • January 2011
    • July 2010
    • May 2010
    • November 2009
    • October 2009
    • March 2009
    • June 2008
    • April 2008
    • October 2007

    Categories

    • Board of Directors
    • Management
    • Press Release
    • Publication
    • Scientific Advisory Board

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    contact

    +1.412.402.9914

    General inquiries: info@noveome.com

    Clinical inquiries: clinical@noveome.com

    Noveome Biotherapeutics, Inc.

    620 Alpha Drive

    Suite 2

    Pittsburgh, PA 15238

    • Company
    • Science
    • Pipeline
    • News
    • Careers

    privacy policy

    terms of use

    © 2020 Noveome Biotherapeutics, Inc. All rights reserved. Noveome® is a registered trademark of Noveome Biotherapeutics, Inc.